Buy & Sell Southwest Airlines Co (LUV) – Southwest Airlines Co Price Today
Aura AI Summary
Key Stats
- $23.45BMarket Cap
- IndustrialsSector
- -12.83%3M Drawdown
- $26.51BEnterprise Value
- 1.5%Dividend Yield
- 65 daysTypical Hold Time
Southwest Airlines Co (LUV) is currently valued at a market capitalization of $23.45B, with an enterprise value of $26.51B. Over the past 52 weeks, Southwest Airlines Co has traded between a low of $29.06 and a high of $54.8, highlighting its annual price range. Over the past three months, Southwest Airlines Co has recorded a drawdown of -12.83%, reflecting recent price volatility. Southwest Airlines Co offers a dividend yield of 1.5%, with the most recent dividend of $0.18 paid on 11 Jun 26. On average, investors hold Southwest Airlines Co for approximately 65 days, indicating typical investor behavior on the platform.
About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Most Recent News
US AI oversight risks restricting frontier AI access to government, raising civil liberties concerns.
Dean Ball, an AI policy expert formerly with the White House, warns that US government plans to centralize AI testing within intelligence agencies could limit access to advanced AI models. This concentration of control might lead to civil liberties i...
Peace deal talks with Iran push oil prices below $80, easing inflation and boosting consumer spending outlook.
A preliminary peace framework between the U.S. and Iran has driven crude oil prices to their lowest in over three months, falling below $80 per barrel, and gasoline prices have dropped about 30% in two months. This deal, still under negotiation with ...
Healthcare ETF XLV struggles in 2026 amid policy shifts and key drug pricing updates.
The Health Care Select Sector SPDR ETF (XLV) is down about 3% year-to-date despite a 14% gain over the past year. The fund's performance hinges on drug pricing policies and key product pricing, especially from Eli Lilly, which dominates XLV with its ...